Winton Group’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-10,577
Closed -$25.2K 880
2023
Q3
$25.2K Sell
10,577
-253
-2% -$602 ﹤0.01% 754
2023
Q2
$19.1K Buy
+10,830
New +$19.1K ﹤0.01% 745